1H NMR studies of drugs with achiral and chiral lanthanide shift reagents: Applications to the anticonvulsant pheneturide

Chirality

Volumn 11, Issue 7, 1999, Pages 529-535

  Byrne, Bridget ^a   Rothchild, Robert ^a,b  

^a JOHN JAY COLLEGE OF CRIMINAL JUSTICE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

(2 phenylbutyryl) urea; Analysis; Enantiomers; Ethylphenacemide; Eu(FOD)3; Eu(HFC)3; N (aminocarbonyl) ethylbenzeneacetamide; One and two dimensional 1H NMR; Stereoisomers

Indexed keywords

ANTICONVULSIVE AGENT; PHENETURIDE; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; LANTHANIDE; UREA;

ARTICLE; CHIRALITY; CRYSTAL STRUCTURE; DRUG STRUCTURE; ENANTIOMER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; STRUCTURE ANALYSIS; CHEMISTRY; CONFORMATION; HYDROGEN BOND; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOISOMERISM; X RAY CRYSTALLOGRAPHY;

ANTICONVULSANTS; CRYSTALLOGRAPHY, X-RAY; HYDROGEN BONDING; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; METALS, RARE EARTH; MOLECULAR CONFORMATION; STEREOISOMERISM; UREA;

EID: 0032589196     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-636X(1999)11:7<529::AID-CHIR3>3.0.CO;2-K     Document Type: Article

References (31)

1. Gold-Aubert P. Synthesis of the antipodes of pheneturide [α-phenyl-α-ethylacetylurea]. Synthesis of a radioactive (+)-pheneturide labeled with carbon-14. Helv Chim Acta 1958;41:1512-1515.
2. Frommel E, Gold-Aubert P, Fleury C. Pharmacological study of d- and l-pheneturide. Arch Int Pharmacodyn 1959;122:15-31.
3. Gold-Aubert P. The psychotherapeutic effects of the optical antipodes of pheneturide. Proc Int Congr Neuro-Pharm, 1st, Rome 1958;313-317 (publ. 1959).
4. Gold-Aubert P. α-Ethyl-α-phenylacetylureas for treatment of epilepsy. Br 864,536 (Sapos SA) Apr. 6, 1961; Chem Abstr 1961;55:19156a.
5. Welder O, Schulze J, König WA. Separation of racemic pharmaceuticals by high-performance liquid chromatography on silica gel modified with carbohydrate residues. J Chromatogr 1987;403:263-270.
6. Wad N. Separation of the enantiomers of pheneturide in serum by high-performance liquid chromatography. J Liq Chromatogr 1988;11 (5):1107-1116.
7. Ruettinger RT, Kim B-H, Fulco AJ. Acylureas: a new class of barbitu-rate-like bacterial cytochrome P-450 inducers. Biochim Biophys Acta 1984;801(3):372-380.
8. Camerman A, Camerman N. Ethylphenacemide and phenacemide: conformational similarities to diphenylhydantoin and stereochemical basis of anticonvulsant activity. Proc Natl Acad Sci USA. 1977;74(3): 1264-1266.
9. Wong MG, Defina JA, Andrews PR. Conformational analysis of clinically active anticonvulsant drugs. J Med Chem 1986;29(4):562-572.
10. Soine WH, Yu C-F, Thomas D, Cao SL, Westkaemper RB, Williams TD. N-Glucosylation of phenobarbital analogs by mouse liver microsomes. Med Chem Res 1996;6(3):174-189.
11. Wenzel TJ. NMR Shift Reagents. Boca Raton FL: CRC Press; 1987.
12. McCreary MD, Lewis DW, Wernick DL, Whitesides GM. The determination of enantiomeric purity using chiral lanthanide shift reagents. J Am Chem Soc 1974;96(4):1038-1054.
13. Goering HL, Eikenberry JN, Koermer GS, Lattimer CJ. Direct determination of enantiomeric compositions with optically active nuclear magnetic resonance lanthanide shift reagents. J Am Chem Soc 1974;96(5):1493-1501.
14. Casy AF. Chiral discrimination by NMR spectroscopy. Trends in Analytical Spectroscopy 1993;12(4):185-189.
15. Uccello-Barretta G. The use of nuclear magnetic resonance in the analysis of chiral compounds. XIX Summer School "A. Corbella," Seminars in Organic Synthesis; 1994 June 20-24; Gargano (BS): Palazzo Feltrinelli, Univ. degli Studi di Milano. p 53-78.
16. Eliel EL, Wilen SH, Mander LN. Stereochemistry of organic compounds. New York: Wiley-Interscience; 1994. p 221-240.
17. Gawley RE, Aubé J. Principles of asymmetric synthesis. Oxford and New York: Pergamon; 1996. p 51-64.
18. Parker D. NMR determination of enantiomeric purity. Chem Rev 1991;91(7):1441-1457.
19. - tions in drugs. Use of achiral and chiral lanthanide shift reagents with mecloqualone, an axially chiral drug of abuse. Rigorous definition of spin systems. Spectrosc Lett 1998;31(2):419-440, and references cited therein.
20. Bynum K, Rothchild R. Analysis of hindered rotation and magnetic anisotropy by NMR. Models for drugs and agricultural compounds. The Diels-Alder adduct of phencyclone with N-carbamoylmaleimide. Spectrosc Lett 1997;30(4):727-749.
21. Sanders JKM, Hunter BK. Modern NMR spectroscopy: a guide for chemists. 2nd ed. Oxford, New York, etc.: Oxford University Press; 1993. p 117, 142-143.
22. Derome AE. Modern NMR techniques for chemistry research, Oxford, New York, etc.: Pergamon Press; 1987. p 227-230.
23. Sanders JKM, Hunter BK. Modern NMR spectroscopy: a guide for chemists. 2nd ed. Oxford, New York, etc.: Oxford University Press; 1993. p 205-211, 216-222.
24. Morrill TC. An introduction to lanthanide shift reagents. In: Morrill TC, editors. Lanthanide shift reagents in stereochemical analysis. New York: VCH Publishers; 1986. Chapter 1. p 1-17.
25. Wenzel TJ. NMR shift reagents. Boca Raton, FL: CRC Press; 1987. p 11-12.
26. Shapiro BL, Shapiro MJ, Godwin AD, Johnston MD, Jr. Lanthanide-induced effects in proton NMR spectra. VIII. Scavenging effects: a problem and a solution. J Magn Reson 1972;8(4):402-405.
27. Wenzel TJ. NMR shift reagents. Boca Raton, FL: CRC Press; 1987. p 23-25, 178-180.
28. Raber DJ. The nature of the LSR-substrate complex. In: Morrill TC, editor. Lanthanide shift reagents in stereochemical analysis. New York: VCH Publishers; 1986. Chapter 3. p 55-105.
29. Raber DJ, Janks CM, Johnston MD Jr, Raber NK. Structure elucidation with lanthanide-induced shifts. 8. Geometry of europium-ketone complexes. J Am Chem Soc 1980;102(21):6591-6594.
30. McConnell HM, Robertson RE. Isotropic nuclear resonance shifts. J Chem Phys 1958;29(6):1361-1365.
31. Vest FB, Soine WH, Westkaemper RB, Soine PJ. Stability of phenobarbital N-glucosides: identification of hydrolysis products and kinetics of decomposition. Pharm Res 1989;6(6):458-465, [see esp. p 460 and Fig. 4A on p 463].